OncoTag

OncoTag is a biotechnology startup founded in 2016 with a focus on personalized medicine in oncology. The company's slogan, "Tratamento do câncer na medida certa," reflects its commitment to providing precise cancer treatments. OncoTag specializes in developing tests to detect genetic prognostic markers and predictive markers, offering valuable insights into tumor nature, patient survival, and the likelihood of response or resistance to specific medications.

The company's flagship product is a test designed for ovarian cancer, enabling the evaluation of patient prognoses. OncoTag's innovation in the realm of personalized oncology positions it at the forefront of biotechnology and healthcare industries. While specific details regarding the company's headquarters and last investment are not available at this time, OncoTag's pioneering approach in developing customized cancer treatments makes it an intriguing prospect for potential investors in the healthcare and biotech sectors.